| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |